2021 Q1 Form 10-Q Financial Statement

#000156459021024996 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $97.73M $96.07M
YoY Change 1.72% 17.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $48.55M $47.93M
YoY Change 1.3% 20.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.891M $2.871M
YoY Change 0.7% 9.04%
% of Gross Profit
Operating Expenses $48.55M $47.93M
YoY Change 1.3% 20.32%
Operating Profit
YoY Change
Interest Expense $7.135M $10.16M
YoY Change -29.77% 4.51%
% of Operating Profit
Other Income/Expense, Net $8.262M $9.819M
YoY Change -15.86% 23.14%
Pretax Income $33.39M -$9.850M
YoY Change -438.99% -193.8%
Income Tax $7.869M -$3.525M
% Of Pretax Income 23.57%
Net Earnings $25.52M -$6.325M
YoY Change -503.51% -178.01%
Net Earnings / Revenue 26.11% -6.58%
Basic Earnings Per Share $2.42 -$0.58
Diluted Earnings Per Share $2.31 -$0.56
COMMON SHARES
Basic Shares Outstanding 10.54M 10.90M
Diluted Shares Outstanding 11.07M 11.25M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.200M $14.70M
YoY Change -51.02% 539.13%
Cash & Equivalents $86.24M $69.32M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.200M $14.70M
YoY Change -51.02% 539.13%
LONG-TERM ASSETS
Property, Plant & Equipment $40.70M $15.16M
YoY Change 168.56% 6.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $93.40M $74.70M
YoY Change 25.03% 92.03%
Total Long-Term Assets $1.091B $1.064B
YoY Change 2.53% 11.88%
TOTAL ASSETS
Total Short-Term Assets $7.200M $14.70M
Total Long-Term Assets $1.091B $1.064B
Total Assets $1.098B $1.079B
YoY Change 1.8% 13.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.90M $29.50M
YoY Change 38.64% 68.57%
Accrued Expenses $29.70M $28.80M
YoY Change 3.13% 8.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $70.60M $58.30M
YoY Change 21.1% 32.5%
LONG-TERM LIABILITIES
Long-Term Debt $744.0M $769.3M
YoY Change -3.29% 24.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $744.0M $769.3M
YoY Change -3.29% 24.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $70.60M $58.30M
Total Long-Term Liabilities $744.0M $769.3M
Total Liabilities $814.7M $827.5M
YoY Change -1.55% 24.32%
SHAREHOLDERS EQUITY
Retained Earnings $196.6M
YoY Change -7.36%
Common Stock $104.9M
YoY Change 4.17%
Preferred Stock
YoY Change
Treasury Stock (at cost) $50.07M
YoY Change 99.93%
Treasury Stock Shares $2.484K
Shareholders Equity $283.6M $251.4M
YoY Change
Total Liabilities & Shareholders Equity $1.098B $1.079B
YoY Change 1.8% 13.15%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $25.52M -$6.325M
YoY Change -503.51% -178.01%
Depreciation, Depletion And Amortization $2.891M $2.871M
YoY Change 0.7% 9.04%
Cash From Operating Activities $35.01M $44.56M
YoY Change -21.42% 45.15%
INVESTING ACTIVITIES
Capital Expenditures $411.0K $1.010M
YoY Change -59.31% -23.19%
Acquisitions
YoY Change
Other Investing Activities $9.100M $1.300M
YoY Change 600.0% -124.53%
Cash From Investing Activities $14.85M $14.00K
YoY Change 105978.57% -100.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.83M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -35.50M -31.68M
YoY Change 12.06% -3.41%
NET CHANGE
Cash From Operating Activities 35.01M 44.56M
Cash From Investing Activities 14.85M 14.00K
Cash From Financing Activities -35.50M -31.68M
Net Change In Cash 14.36M 12.89M
YoY Change 11.42% -244.95%
FREE CASH FLOW
Cash From Operating Activities $35.01M $44.56M
Capital Expenditures $411.0K $1.010M
Free Cash Flow $34.60M $43.55M
YoY Change -20.54% 48.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2021Q1 us-gaap Interest Expense
InterestExpense
7135000
CY2020Q1 us-gaap Interest Expense
InterestExpense
10159000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
11834000
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1546000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1563000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
25522000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
283636000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
302783000
CY2019Q4 rm New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effects Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectsOfChangeOnEquityOrNetAssets1
-45922000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
25522000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-6325000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11362000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2891000
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-19000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1563000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1419000
CY2021Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
785000
CY2020Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-29000
CY2021Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-245000
CY2020Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5228000
CY2021Q1 rm Increase Decrease In Lease Assets
IncreaseDecreaseInLeaseAssets
536000
CY2020Q1 rm Increase Decrease In Lease Assets
IncreaseDecreaseInLeaseAssets
291000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-302000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-854000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1739000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1353000
CY2021Q1 rm Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
511000
CY2020Q1 rm Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
333000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42325000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44556000
CY2021Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-9100000
CY2020Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-1289000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
769000
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
265000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
411000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1010000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7920000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14000
CY2021Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-129581000
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-38684000
CY2021Q1 us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-5695000
CY2021Q1 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
7985000
CY2020Q1 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
5949000
CY2021Q1 us-gaap Other Income
OtherIncome
2467000
CY2020Q1 us-gaap Other Income
OtherIncome
3128000
CY2021Q1 us-gaap Revenues
Revenues
97731000
CY2020Q1 us-gaap Revenues
Revenues
96074000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11362000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
49522000
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
28851000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
29511000
CY2021Q1 us-gaap Occupancy Net
OccupancyNet
6020000
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
5227000
CY2021Q1 us-gaap Marketing Expense
MarketingExpense
2710000
CY2020Q1 us-gaap Marketing Expense
MarketingExpense
1686000
CY2021Q1 us-gaap Other Expenses
OtherExpenses
8262000
CY2020Q1 us-gaap Other Expenses
OtherExpenses
9819000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45843000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46243000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33391000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9850000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7869000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3525000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
25522000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6325000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.42
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10543000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10897000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11066000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11253000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
272123000
CY2021Q1 us-gaap Dividends Cash
DividendsCash
2206000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
49522000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2871000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
7230000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
9082000
CY2020Q1 us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
8313000
CY2021Q1 us-gaap Proceeds From Repayments Of Accounts Receivable Securitization
ProceedsFromRepaymentsOfAccountsReceivableSecuritization
118567000
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2506000
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
78000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2638000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1231000
CY2021Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
2196000
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11834000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35883000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31680000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14362000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12890000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71876000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56427000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86238000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69317000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-199000
CY2020Q4 us-gaap Financing Receivable Percent Past Due1
FinancingReceivablePercentPastDue1
0.053
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1136259000
CY2020Q4 rm Finance Receivable Net Percent
FinanceReceivableNetPercent
1.000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
32239000
CY2020Q4 rm Financing Receivable Recorded Investment Nonaccrual Status Percent
FinancingReceivableRecordedInvestmentNonaccrualStatusPercent
0.028
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2087000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2061000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2202000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2473000
CY2021Q1 us-gaap Cash
Cash
7226000
CY2020Q4 us-gaap Cash
Cash
8052000
CY2020Q1 us-gaap Cash
Cash
14668000
CY2019Q4 us-gaap Cash
Cash
2263000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
79012000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
63824000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
54649000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
54164000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86238000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71876000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69317000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56427000
CY2021Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Note 1. Nature of Business </p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Regional Management Corp. (the “<span style="text-decoration:underline;">Company</span>”) was incorporated and began operations in 1987. The Company is engaged in the consumer finance business, offering small loans, large loans, retail loans, and related payment and collateral protection insurance products. The Company previously offered automobile purchase loans, but ceased such originations in November 2017. As of March 31, 2021, the Company operated under the name “Regional Finance” in 365 branch locations across 11 states in the Southeastern, Southwestern, Mid-Atlantic, and Midwestern United States. </p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s loan volume and contractual delinquency follow seasonal trends. Demand for the Company’s small and large loans is typically highest during the second, third, and fourth quarters, which the Company believes is largely due to customers borrowing money for vacation, back-to-school, and holiday spending. Loan demand has generally been the lowest during the first quarter, which the Company believes is largely due to the timing of income tax refunds. Delinquencies generally reach their lowest point in the first half of the year and rise in the second half of the year. The current expected credit loss (“<span style="text-decoration:underline;">CECL</span>”) accounting model requires earlier recognition of credit losses compared to the prior incurred loss approach. This could result in larger allowance for credit loss releases in periods of portfolio liquidation, and larger provisions for credit losses in periods of portfolio growth compared to prior years. Consequently, the Company experiences seasonal fluctuations in its operating results. However, changes in borrower assistance programs and customer access to external economic stimulus measures related to the novel strain of coronavirus (“<span style="text-decoration:underline;">COVID-19</span>”) have impacted the Company’s typical seasonal trends for loan volume and delinquency. </p>
CY2021Q1 us-gaap Number Of Stores
NumberOfStores
365
CY2021Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
11
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Calibri;text-transform:none;font-variant: normal;">Use of estimates:<span style="font-weight:normal;font-style:normal;"> The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and disclosure of contingent assets and liabilities for the periods indicated in the financial statements. Actual results could differ from those estimates. </span></p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Material estimates that are particularly susceptible to change relate to the determination of the allowance for credit losses, the fair value of share-based compensation, the valuation of deferred tax assets and liabilities, and the fair value of financial instruments. </p>
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Calibri;text-transform:none;font-variant: normal;">Reclassifications:<span style="font-style:normal;"> </span><span style="font-weight:normal;font-style:normal;">Certain prior-period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income or stockholders’ equity. </span></p>
CY2021Q1 rm Threshold Period Past Due For Write Off Of Financing Receivables
ThresholdPeriodPastDueForWriteOffOfFinancingReceivables
P180D
CY2021Q1 rm Bankruptcy Threshold Period Past Due For Write Off Of Financing Receivables
BankruptcyThresholdPeriodPastDueForWriteOffOfFinancingReceivables
P60D
CY2021Q1 rm Finance Receivables Income Recognition Contractual Delinquent Period
FinanceReceivablesIncomeRecognitionContractualDelinquentPeriod
P90D
CY2021Q1 us-gaap Financing Receivable Threshold Period Past Due Writeoff
FinancingReceivableThresholdPeriodPastDueWriteoff
P90D
CY2021Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1105603000
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1136259000
CY2021Q1 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
11800000
CY2020Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
12600000
CY2021Q1 rm Number Of Fico Band Categories
NumberOfFICOBandCategories
6
CY2021Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
217141000
CY2021Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
625574000
CY2021Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
216738000
CY2021Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
35258000
CY2021Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
8308000
CY2021Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
2584000
CY2021Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1105603000
CY2021Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
47720000
CY2021Q1 us-gaap Financing Receivable Percent Past Due1
FinancingReceivablePercentPastDue1
0.043
CY2021Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1105603000
CY2021Q1 rm Finance Receivable Net Percent
FinanceReceivableNetPercent
1.000
CY2021Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
28884000
CY2021Q1 rm Financing Receivable Recorded Investment Nonaccrual Status Percent
FinancingReceivableRecordedInvestmentNonaccrualStatusPercent
0.026
CY2020Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
60450000
CY2021Q1 us-gaap Interest Receivable
InterestReceivable
2400
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
150000000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
62200000
CY2020Q1 rm Impact Of Cecl Adoption On Beginning Allowance
ImpactOfCeclAdoptionOnBeginningAllowance
60100000
CY2021Q1 rm Covid Reserve Build Release
COVIDReserveBuildRelease
-6600000
CY2020Q1 rm Covid Reserve Build Release
COVIDReserveBuildRelease
23900000
CY2021Q1 rm Portfolio Growth Reserve Build
PortfolioGrowthReserveBuild
-3800000
CY2020Q1 rm Portfolio Growth Reserve Build
PortfolioGrowthReserveBuild
-3800000
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
139600000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
142400000
CY2021Q1 rm Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
0.126
CY2020Q1 rm Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
0.129
CY2021Q1 rm Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
0.126
CY2020Q1 rm Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
0.129
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
150000000
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
11362000
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
22769000
CY2021Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
1007000
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
139600000
CY2021Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1105603000
CY2021Q1 rm Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
0.126
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
62200000
CY2020Q1 rm Impact Of Cecl Adoption On Beginning Allowance
ImpactOfCeclAdoptionOnBeginningAllowance
60100000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
49522000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
30680000
CY2020Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
1258000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
142400000
CY2020Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1102285000
CY2020Q1 rm Allowance Percentage Of Finance Receivables
AllowancePercentageOfFinanceReceivables
0.129
CY2021Q1 rm Tdr Number Of Loans Modified
TDRNumberOfLoansModified
1412
CY2021Q1 rm Tdr Modified Loans Balance
TDRModifiedLoansBalance
4590000
CY2020Q1 rm Tdr Number Of Loans Modified
TDRNumberOfLoansModified
3095
CY2020Q1 rm Tdr Modified Loans Balance
TDRModifiedLoansBalance
9362000
CY2021Q1 rm Tdr Number Of Defaulted Loans
TDRNumberOfDefaultedLoans
428
CY2021Q1 rm Tdr Finance Receivables Defaulted
TDRFinanceReceivablesDefaulted
1264000
CY2020Q1 rm Tdr Number Of Defaulted Loans
TDRNumberOfDefaultedLoans
2516
CY2020Q1 rm Tdr Finance Receivables Defaulted
TDRFinanceReceivablesDefaulted
7325000
CY2021Q1 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
600000000.0
CY2021Q1 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
600000000
CY2020Q4 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
265000
CY2021Q1 rm Derivative Interest Rate Cap Purchases
DerivativeInterestRateCapPurchases
602000
CY2020Q1 rm Derivative Interest Rate Cap Purchases
DerivativeInterestRateCapPurchases
114000
CY2021Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
785000
CY2020Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
-29000
CY2021Q1 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
1652000
CY2020Q1 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
85000
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
752200000
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8196000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
744004000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
768909000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
6661000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
762248000
CY2021Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
573110000
CY2020Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
438082000
CY2021Q1 us-gaap Line Of Credit Facility Commitment Fee Description
LineOfCreditFacilityCommitmentFeeDescription
The Company pays an unused line fee between 0.375% and 0.65% based upon the average outstanding balance of the facility.
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2021Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
352000
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
11800000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2021Q1 rm Provision For Corporate Taxes
ProvisionForCorporateTaxes
8348000
CY2020Q1 rm Provision For Corporate Taxes
ProvisionForCorporateTaxes
-3577000
CY2021Q1 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
-479000
CY2020Q1 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
52000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7869000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3525000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
25522000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6325000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10543000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10897000
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
523000
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
356000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11066000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11253000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.42
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4783
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4488
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0263
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0064
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0071
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
908000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.73
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
137000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.44
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
137000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.44
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
16.30
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
905000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.01
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11444000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
648000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.49
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9175000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
10.52
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
7.58
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2861000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
219000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
353000

Files In Submission

Name View Source Status
0001564590-21-024996-index-headers.html Edgar Link pending
0001564590-21-024996-index.html Edgar Link pending
0001564590-21-024996.txt Edgar Link pending
0001564590-21-024996-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rm-10q_20210331.htm Edgar Link pending
rm-10q_20210331_htm.xml Edgar Link completed
rm-20210331.xsd Edgar Link pending
rm-20210331_cal.xml Edgar Link unprocessable
rm-20210331_def.xml Edgar Link unprocessable
rm-20210331_lab.xml Edgar Link unprocessable
rm-20210331_pre.xml Edgar Link unprocessable
rm-ex311_9.htm Edgar Link pending
rm-ex312_6.htm Edgar Link pending
rm-ex321_7.htm Edgar Link pending
Show.js Edgar Link pending